Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Faes Farma ( (ES:FAE) ) has shared an update.
Faes Farma, S.A. has completed the acquisition of Laboratorios Edol, a leading Portuguese ophthalmology company, as part of its strategic plan to enhance its presence in Portugal and expand its international growth. This acquisition, valued at 75 million euros, is expected to create synergies with Faes Farma’s current R&D efforts and support business growth in new therapeutic areas.
More about Faes Farma
Faes Farma, S.A. operates in the pharmaceutical industry, focusing on the development and commercialization of pharmaceutical products. The company is expanding its portfolio and market presence, particularly in the field of ophthalmology, which is a high-growth area due to factors like an aging population and increased screen use.
Average Trading Volume: 548,760
Technical Sentiment Signal: Buy
Current Market Cap: €1.34B
Learn more about FAE stock on TipRanks’ Stock Analysis page.